Peptide–drug conjugates (PDCs): a novel trend of research and development on targeted therapy, hype or hope?

Peptide–drug conjugates (PDCs) are the next generation of targeted therapeutics drug after antibody–drug conjugates (ADCs), with the core benefits of enhanced cellular permeability and improved drug selectivity. Two drugs are now approved for market by US Food and Drug Administration (FDA), and in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Chen, Yu, Lifeng, Miao, Yuxi, Liu, Xinli, Yu, Zhaojin, Wei, Minjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978859/
https://www.ncbi.nlm.nih.gov/pubmed/36873165
http://dx.doi.org/10.1016/j.apsb.2022.07.020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978859/
https://www.ncbi.nlm.nih.gov/pubmed/36873165
http://dx.doi.org/10.1016/j.apsb.2022.07.020

Ejemplares similares